Latest Breaking News On - மகேஷ் தோஷி - Page 1 : comparemela.com

Drugmakers cry ‘monopoly’ as Modi govt picks 1 firm each to make over 20 key raw materials Himani Chandna © Provided by The Print New Delhi: India’s weapon to fight its dependence on Chinese medicine imports the Production-Linked Incentive scheme may end up creating a monopoly of just a few drugmakers, and the pharma lobby has expressed its concern about this to the Narendra Modi government. The PLI scheme launched by the government in July provides monetary incentives to increase the production of 41 critical raw materials, including active pharmaceutical ingredients (APIs), intermediates and key starting materials, distributed in four categories, that are required for manufacturing final formulations (medicines) in India.

New delhiSun pharmaNarendra modiAurobindo pharmaMansukh mandaviyaMahesh doshiShreyas sharmaTorrent pharmaceuticalsCentrient pharmaceuticalsMinistry of chemicalsJubilant life sciencesDepartment of pharmaceuticals doDepartment of pharmaceuticalsIndian drug manufacturers associationProduction linked incentiveTelangana based honour labs